#CompanyWithAuditAndSupervisoryCommittee

Amada Co., Ltd. will transition to a company with an audit and supervisory committee as of June 26, 2026, and implement changes in directors and auditors. Yoshiko Fujii is scheduled to be appointed as a new outside director.

Asuka Pharmaceutical Holdings Co., Ltd. has resolved to transition to a company with an audit and supervisory committee, subject to approval at the 5th Annual General Meeting of Shareholders scheduled for June 24, 2026.

Kyowa Kirin Co., Ltd. plans to propose partial amendments to the Articles of Incorporation at the Annual General Meeting of Shareholders scheduled for March 19, 2026, aimed at adding new business purposes and transitioning to a company with an audit and supervisory committee.

Kobayashi Pharmaceutical Co., Ltd. plans to propose amendments to its articles of incorporation at the 108th Annual General Meeting of Shareholders scheduled for March 27, 2026, to transition to a company with an audit and supervisory committee, aiming to strengthen the board of directors' supervisory functions and improve management agility.

Subject to approval at the Annual General Meeting of Shareholders on March 27, 2026, the company will transition from a company with a board of auditors to a company with an Audit and Supervisory Committee and has decided on new executive candidates.

Takara Tomy Company, Ltd. announced its plan to transition from a company with a board of auditors to a company with an audit and supervisory committee, subject to approval at the annual shareholders meeting on June 25, 2026.